Michael J. Luzzio, Chairperson
Senior Research Investigator Novartis Institutes for BioMedical Research, Cambridge, MA michael.luzzio@novartis.com
Stephen A. Munk, Ph.D. Chairperson-Elect
Chief Executive Officer and President Ash Stevens Inc., Detroit, MI samunk@ashstevens.com
Billy W. Day, Ph.D. Past Chairperson
Professor, Dept. of Pharmacy Sciences University of Pittsburgh School of Pharmacy, Pittsburgh, PA bday@pitt.edu
Stacie S. Canan, Ph.D. (2012-2014)
Executive Director, Chemistry Celgene Corporation, San Diego, CA scanan@celgene.com
Michael P. Dillon, Ph.D. (2012-2014)
Executive Director and Head, Chemical Sciences Novartis Institutes for BioMedical Research, Emeryville, CA michael.dillon@novatis.com
John A. Katzenellenbogen, Ph.D. (2013-2015)
Professor, Dept. of Chemistry University of Illinois at Urbana-Champaign, Urbana, IL jkatzene@illinois.edu
|
George S. Sheppard, Ph.D. (2013-2015)
Associate Research Fellow Abbvie george.s.sheppard@abbvie.com
David E. Uehling, Ph.D. (2012-2014)
Senior Chemist Ontario Institute for Cancer Research, Toronto, Canada daviduehling@gmail.com
Gregory D. Vite, Ph.D. (2011-2015)
Executive Director, Oncology Chemistry Bristol-Myers Squibb Co., Princeton, NJ gregory.vite@bms.com
Shaomeng Wang, Ph.D. (2013-2015)
Professor of Medicine, Pharmacology and Medicinal Chemistry University of Michigan Comprehensive Cancer Center Ann Arbor, MI shaomeng@umich.edu
Wendy B. Young, Ph.D. (2012-2014)
Associate Director, Discovery Chemistry Genentech Inc., South San Francisco, CA young.wendy@gene.com
|